Abdominal Neoplasms Clinical Trial
Official title:
Multicenter, Randomized, Open-label Study to Evaluate the Efficacy and Safety of Enoxaparin Sodium (RP54563) 20mg Bid for 14 Days for Prevention of Venous Thromboembolism in Patients With Curative Abdominal Cancer Surgery. Physical Prophylaxis Only Arm [Intermittent Pneumatic Compression (IPC)] Will be Used as an Indicator of Event Rates.
The primary objective of this study is to evaluate the effects of enoxaparin on venous thromboembolism incidence and bleeding rate (major and minor bleeding) in patients undergoing curative abdominal cancer surgery. The secondary objective is evaluate the incidence of adverse events of enoxaparin in these patients.
n/a
Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02653469 -
Augmented Pulse Pressure Variation to Predict Fluid Responsiveness in Open Laparotomy
|
N/A | |
Completed |
NCT04032951 -
22 Gauge Needle for EUS Guided Tissue Acquisition of Samples for Histologic Examination
|
N/A | |
Completed |
NCT01399814 -
Restricted Intravenous Fluid Regime Effects on Immunological Indicators of Elderly Patients Operated for Abdominal Cancer
|
Phase 3 | |
Completed |
NCT02307253 -
EUS GUIDED Transduodenal Biopsy Using the 19G Flex
|
N/A | |
Completed |
NCT00186953 -
Determination of a Safe Dose of Optison in Pediatric Patients With Solid Tumors
|
Phase 1 | |
Completed |
NCT03002909 -
Continuous Pre-peritoneal Wound Infiltration Versus Epidural Analgesia in Cancer Surgery
|
N/A | |
Recruiting |
NCT02557256 -
Malignant Pediatric Pelvic Tumors: A Retrospective Study
|